Adaptive Biotechnologies Corporation Common Stock (ADPT)
NASDAQ
Closed
Oct 9, 2026
Day's Range
25.9752 wk Range
12.00Overview - ADPT - Adaptive Biotechnologies Corporation Common Stock
Key Statistics
Valuation
Enterprise Value
4.77B
P/E (Trailing)
‪-75.51‬
P/E (Forward)
‪-161.81‬
PEG Ratio
‪-1.60‬
Price / Sales (TTM)
‪15.24‬
Price / Book
‪32.77‬
EV / EBITDA
‪-223.70‬
Profitability
Gross Margin
‪71.81%‬
Profit Margin
‪-20.72%‬
Operating Margin
‪-22.04%‬
Return on Assets
‪-4.11%‬
Return on Equity
‪-38.75%‬
Ownership
Shares Outstanding
159.05M
Float
125.48M
Short % of Shares Outstanding
‪10.68%‬
Held by Insiders
‪1.29%‬
Held by Institutions
‪99.41%‬
Price stats
Beta
‪2.09‬
50-Day Avg
‪24.84‬
200-Day Avg
‪18.26‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
8 analysts
Average price target
‪$ 25.07‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ADPT - Adaptive Biotechnologies Corporation Common Stock
Peers - ADPT - Adaptive Biotechnologies Corporation Common Stock
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- ADPTNASDAQAdaptive Biotechnologies Corp4.69BMarket Cap+54.26%52-week change-75.51P/E (Trailing)‪-20.72%‬Profit Margin
- NTRANASDAQNatera, Inc.59.14BMarket Cap+58.48%52-week change-269.84P/E (Trailing)‪-7.10%‬Profit Margin
- ILMNNASDAQIllumina Inc.41.22BMarket Cap+63.00%52-week change50.85P/E (Trailing)‪18.33%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.40.86BMarket Cap-22.26%52-week change36.06P/E (Trailing)‪25.03%‬Profit Margin
- GHNASDAQGuardant Health Inc.23.86BMarket Cap+64.35%52-week change-53.55P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings, Inc.16.86BMarket Cap+14.16%52-week change35.48P/E (Trailing)‪17.66%‬Profit Margin
- ICLRNASDAQICON plc12.50BMarket Cap-17.51%52-week change170.58P/E (Trailing)‪0.32%‬Profit Margin
Profile Summary - ADPT - Adaptive Biotechnologies Corporation Common Stock
About
Adaptive Biotechnologies Corporation Common Stock represents the equity of Adaptive Biotechnologies Corporation, a commercial-stage biotechnology company focused on immune medicine. The company develops products and services that use immunosequencing, proprietary chemistry, computational biology, and machine learning…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
